Keyphrases
Botulinum Neurotoxin (BoNT)
100%
Parkinson's Disease
72%
Cerebral Palsy children
63%
Balance Evaluation Systems Test
54%
Lower Extremity
48%
Botulinum Toxin Injection
46%
Hypertonicity
37%
Spasticity
33%
Botox
32%
Physical Therapists
30%
High Dose
24%
Physical Therapy
22%
Muscle Strength
21%
Adverse Events
21%
Cerebral Palsy
20%
Clinical Utility
18%
Teaching Implementation
18%
Spinal Cord Injury
18%
Mixed-methods Study
18%
Practical Implementation
18%
Test Reliability
18%
Systemic Effects
18%
Iatrogenic Botulism
18%
Healthcare
18%
Complex Patients
18%
Reliability Validity
18%
Gait Balance
18%
Assessment Template
18%
Capacity Building
18%
Pelvic Fracture
18%
US Medicare
18%
Hip Fracture
18%
Medicare Beneficiaries
18%
Balance Assessment
18%
Evaluation Assessment
18%
Test Evaluation
18%
Remote Effect
18%
Backward Disequilibrium
18%
Test Validity
18%
Functional Gait Assessment
18%
Therapeutic Injections
18%
Balanced System
18%
Profile Management
18%
Test Specificity
18%
Forefoot Ulceration
18%
Relative Mortality
18%
Plantar Pressure
18%
Diabetic
18%
Peripheral Neuropathy
18%
Toxin Effects
18%
Nursing and Health Professions
Parkinson's Disease
54%
Botulinum Toxin A
54%
Physiotherapy
40%
Physiotherapist
31%
Diseases
29%
Clostridium Botulinum Type A
27%
Hypertonic Solution
22%
Adverse Event
20%
Study Participant
18%
Pelvis Fracture
18%
Diabetes Mellitus
18%
Sensitivity and Specificity
18%
Berg Balance Scale
18%
Weakness
18%
Hip Fracture
18%
Medicare
18%
Clinical Examination
18%
Ulcer
18%
Drug Megadose
18%
Cerebral Palsy
18%
Cervical Dystonia
18%
Clinical Management
18%
Neuropathy
18%
Cerebrovascular Accident
18%
Confidence Interval
12%
Hazard Ratio
12%
Side Effect
12%
Psychometry
9%
Assisted Living Facility
9%
Walking Speed
9%
Systematic Review
9%
Nursing Home
9%
Practice Guideline
9%
Stroke Rehabilitation
9%
Patient Acuity
9%
Hemiarthroplasty
9%
Clinical Practice
9%
Performance Oriented Mobility Assessment
9%
Patient Care
9%
Base
9%
Femoral Neck Fracture
9%
Home Care
9%
Test Retest Reliability
8%
Motor Dysfunction
7%
Content Analysis
6%
Mobilization
6%
Receiver Operating Characteristic
5%
Interrater Reliability
5%
Correlation Coefficient
5%
Plantar Ulcer
5%
Medicine and Dentistry
Botulinum Toxin A
83%
Spastic Diplegia
60%
Clostridium Botulinum Type A
36%
Hypertonic Solution
29%
Hypertonicity
29%
Spasticity
28%
Drug Megadose
22%
Botulism
21%
Adverse Event
20%
Forefoot
18%
Spasmodic torticollis
18%
Pediatrics Patient
18%
Clinical Management
18%
Diabetes Mellitus
18%
Venous Ulcer
18%
Prospective Study
18%
Neuropathy
18%
Diseases
18%
Muscle Strength
16%
Upper Limb
9%
Muscle Function
8%
Physiotherapist
8%
Range of Motion
6%
Muscle Tone
6%
Dystonia
6%
Mobilization
6%
Intoxication
6%
Placebo
5%
Plantar Ulcer
5%